you are viewing a single comment's thread.
Teva looks good in terms of it's value. If you like healthcare what about ESRX? It's a bit pricier.ESRX rev. growth ttm vs prior ttm= 82.18%TEVA by comparison= 15.99%Both look like good buys to me. Just different parts of the healthcare boat.
I've looked at ESRX from time to time, sure wish I'd been long years ago. 2009 presented one of the few good buying dips.But I still prefer TEVA since they produce a product rather than a service.... just me.
I have always been interested in ESRX but never bot. Could be a good opportunity now.